Xiaomeng Liu

627 total citations
33 papers, 289 citations indexed

About

Xiaomeng Liu is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Xiaomeng Liu has authored 33 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Xiaomeng Liu's work include Cancer Immunotherapy and Biomarkers (3 papers), Adenosine and Purinergic Signaling (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Xiaomeng Liu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Adenosine and Purinergic Signaling (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Xiaomeng Liu collaborates with scholars based in China, Netherlands and United States. Xiaomeng Liu's co-authors include Gabriël J.E. Rinkel, Shuangshuang Tian, Jianjun Huang, Cheng‐Ming Sun, Tong Wang, Xian Li, Cong Wang, Xiaoyan Luo, Xudong Liu and Nan Qiao and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Xiaomeng Liu

27 papers receiving 289 citations

Peers

Xiaomeng Liu
Graziella Marino Italy
Felipe Osório Costa Brazil
Minodora Andor Romania
Hossein Ali Ebrahimi Iran
Juan Jiang China
Ali Jafarzadeh Esfehani Iran
Fangfang Zhang China
J. Brouwer Netherlands
Jieying Zhang China
Graziella Marino Italy
Xiaomeng Liu
Citations per year, relative to Xiaomeng Liu Xiaomeng Liu (= 1×) peers Graziella Marino

Countries citing papers authored by Xiaomeng Liu

Since Specialization
Citations

This map shows the geographic impact of Xiaomeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomeng Liu more than expected).

Fields of papers citing papers by Xiaomeng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomeng Liu. The network helps show where Xiaomeng Liu may publish in the future.

Co-authorship network of co-authors of Xiaomeng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomeng Liu. A scholar is included among the top collaborators of Xiaomeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomeng Liu. Xiaomeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Zhen, Jianhui Yang, Yueyue Chen, et al.. (2025). m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis. Cell Death and Disease. 16(1). 784–784.
2.
Li, Zhe, Xiaomeng Liu, Fei Tan, et al.. (2025). Novel Indoleamine-2,3-Dioxygenase-Targeted Pt(IV) Prodrugs Regulate the Tumor Immune Microenvironment to Achieve Chemoimmunotherapy In Vitro and In Vivo. Journal of Medicinal Chemistry. 68(4). 4352–4372. 3 indexed citations
3.
4.
Liu, Xiaomeng, Zhe Li, Jiaqian Wang, et al.. (2025). A novel platinum(IV) prodrug, gramine-Pt(IV) enhances chemoimmunotherapy by activating cGAS-STING and modulating TGF-β-MHC-I axis. Drug Resistance Updates. 81. 101252–101252. 3 indexed citations
5.
Huang, Junjun, Lüpei Du, Xiaomeng Liu, et al.. (2025). Nitric oxide confers cadmium tolerance in soybean via cell wall modification, transporter regulation, and activation of stress signaling pathways. Plant Physiology and Biochemistry. 229(Pt B). 110455–110455.
6.
Wang, Yilin, Siyu Wang, Fengyi Li, et al.. (2025). Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study. Cancer Immunology Immunotherapy. 74(6). 186–186. 1 indexed citations
7.
Liu, Xiaomeng, et al.. (2025). Proteomics Insights Into Gingival Aging: The Role of Oxidative Stress and Key Signaling Pathways. International Dental Journal. 75(5). 100903–100903.
8.
Liu, Xiaomeng, Zhe Li, Xiaoya Wang, et al.. (2025). Self-assembled HO-1i-Pt(IV) nanomedicine targeting p38/MAPK and MDR pathways for cancer chemo-immunotherapy. Journal of Controlled Release. 379. 797–813. 3 indexed citations
9.
10.
Liu, Xiaomeng, Shuping Ge, & Aijun Zhang. (2024). Pediatric Cardio-Oncology: Screening, Risk Stratification, and Prevention of Cardiotoxicity Associated with Anthracyclines. Children. 11(7). 884–884. 1 indexed citations
11.
Liu, Xiaomeng, Xinrui He, Qian Chen, et al.. (2024). NIR Light and GSH Dual-Responsive Upconversion Nanoparticles Loaded with Multifunctional Platinum(IV) Prodrug and RGD Peptide for Precise Cancer Therapy. ACS Applied Materials & Interfaces. 16(31). 40753–40766. 11 indexed citations
12.
13.
Liu, Xudong, et al.. (2023). Antiaging effects of dietary supplements and natural products. Frontiers in Pharmacology. 14. 1192714–1192714. 29 indexed citations
14.
Shi, Yan, Hui Pang, Lichun Sun, et al.. (2023). Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial. BMC Cancer. 23(1). 463–463. 6 indexed citations
15.
Liu, Xiaomeng, Zhe Li, Xinrui He, et al.. (2022). Dual-targeting of the aromatase binding domain of heme and androstenedione by Pt(iv) prodrugs: a new treatment for postmenopausal breast cancer. Inorganic Chemistry Frontiers. 9(14). 3470–3483. 10 indexed citations
16.
17.
Liu, Xiaomeng, et al.. (2017). Chlorpromazine dose for people with schizophrenia. Cochrane Database of Systematic Reviews. 2017(4). 26 indexed citations
18.
Liu, Xiaomeng, et al.. (2015). Acrokeratosis Paraneoplastica. New England Journal of Medicine. 373(22). 2161–2161. 2 indexed citations
19.
Gao, Guan-Qi, Xueyuan Heng, Yue-Li Wang, et al.. (2014). Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes. Experimental and Therapeutic Medicine. 8(4). 1191–1196. 5 indexed citations
20.
Liu, Xiaomeng, et al.. (2009). Chlorpromazine Dose for People With Schizophrenia. Schizophrenia Bulletin. 35(3). 491–492. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Graziella Marino Breakdown of academic impact, for papers by Felipe Osório Costa Breakdown of academic impact, for papers by Minodora Andor Breakdown of academic impact, for papers by Hossein Ali Ebrahimi Breakdown of academic impact, for papers by Juan Jiang Breakdown of academic impact, for papers by Ali Jafarzadeh Esfehani Breakdown of academic impact, for papers by Fangfang Zhang Breakdown of academic impact, for papers by J. Brouwer Breakdown of academic impact, for papers by Jieying Zhang
Rankless by CCL
2026